
1. indian j pharmacol. 2008 jun;40(3):107-10. doi: 10.4103/0253-7613.42302.

immunomodulatory effect tinospora cordifolia extract human
immuno-deficiency virus positive patients.

kalikar mv, thawani vr, varadpande uk, sontakke sd, singh rp, khiyani rk.

objectives: assess safety efficacy tce human immuno-deficiency
virus positive patients.
materials methods: efficacy tinospora cordifolia extract (tce) hiv
positive patients assessed randomized double blind placebo controlled
trial. 68 hiv positive participants randomly assigned two groups to
receive either tce placebo six months. clinical examination tlc,
dlc, esr, platelet count, hemoglobin cd4 count done. hematological
investigations repeated bimonthly intervals cd4 count repeated at
the end study. patients clinically reviewed monthly intervals 
compliance, refill adr monitoring. drugs decoded end the
trial.
results: tce treatment caused significant reduction eosinophil count and
hemoglobin percentage. 60% patients receiving tce 20% placebo reported
decrease incidence various symptoms associated disease. of
the common complaints reported patients tce anorexia, nausea, vomiting
and weakness.
conclusion: tinospora cordifolia extract, plant derived immunostimulant,
significantly affected symptoms hiv. validated clinical
evaluation. however objective parameters studied us, back 
up. tinospora cordifolia could used adjunct hiv/aids management.

doi: 10.4103/0253-7613.42302 
pmcid: pmc2792597
pmid: 20040936 

